A Clinical Trial Assessing Safety of MF101 for Hot Flushes
Status unconfirmed · Phase 1
Conditions studied: Hot Flashes
In brief
This Phase 1, open label, randomized clinical trial will enroll 40 generally healthy, postmenopausal women aged 40-65 years old. Women will be randomized to one of two oral doses of MF101 for 4 weeks. Participants will be recruited at 3 clinical sites in the United States.
Key facts
- Study ID
- NCT01300078
- Run by
- Bionovo
- People needed
- 40
- Starts
- 2011-03-01
- Expected to finish
- 2011-06-01
- Last updated by the study team
- 2011-06-02
Who can join
Age: 40 and older, up to 65. Sex: female. Healthy volunteers: accepted.
Where it is running
- Alta Bates, Jordan Research and Education Institute (REDI) — Berkeley, California, United States
- Clinical Trials Research — Lincoln, California, United States
- Northern California Research — Sacramento, California, United States
- Medical Center for Clinical Research — San Diego, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.